**Chapter 7**

*The Universe of Escherichia coli*

[116] Nagano T, Kitahara R, Nagai S. An attenuated mutant of avian pathogenic *Escherichia coli* serovar O78: A possible live vaccine strain for prevention of avian colibacillosis. Microbiology and Immunology. 2012;**56**:605-612. DOI: 10.1111/j.1348-0421.2012.00482.x

[117] La Ragione RM, Woodward MJ, Kumar M, Rodenberg J, Fan H, Wales AD, et al. Efficacy of a live attenuated *Escherichia coli* O78:K80 vaccine in chickens and turkeys. Avian Diseases. 2013;**57**:273-279. DOI:

10.1637/10326-081512-Reg.1

[118] Kwaga JK, Allan BJ, van der Hurk JV, Seida H, Potter AA. A *carAB* mutant of avian pathogenic *Escherichia coli* serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infection and

Immunity. 1994;**62**:3766-3772

[120] Gregersen RH, Christensen H, Ewers C, Bisgaard M. Impact of *Escherichia coli* vaccine on parent stock mortality, first week mortality of broilers and population diversity of *E. coli* in vaccinated flocks. Avian Pathology. 2010;**39**:287-295. DOI: 10.1080/03079457.2010.495744

10.1637/7093

[119] Kariyawasam S, Wilkie BN, Gyles CL. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic *Escherichia coli*. Avian Diseases. 2004;**48**:287-299. DOI:

**120**
